CONMED Corp — Director's Dealing 2012

Mar 19, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-03-15

Reporting Person: CORASANTI JOSEPH J (President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-15	Common Stock	M	25509	$17.74	Acquired	102670	Direct
2012-03-15	Common Stock	S	25509	$29.4679	Disposed	77161	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-15	Options To Purchase Common Stock	$17.74	M	25509	Disposed	2013-05-20	Common Stock (25509)	Direct

Footnotes

F1: 5 year vesting schedule, 20% vest each year starting 5/20/2004.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.40 to $29.646. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.